Resources

An assessment tool known as Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT) is effective in screening patients of varying ethnic backgrounds for prediabetes, according to the results of a new study. Researchers say the test is an improvement over using BMI alone or using a list of risk …

Treatment with cholesterol-lowering rosuvastatin reduced coronary events by 44% — including overall mortality — among patients who are asymptomatic for heart disease but have high levels of high-sensitivity C-reactive protein and low levels of low-density lipoprotein (LDL) cholesterol.

Twice as many older Americans are hospitalized with heart failure than 25 years ago, reflecting an aging population and success in keeping people alive after heart attacks and disease damage the organ, researchers said.

High-sensitivity C-reactive protein modestly improves prediction of global cardiovascular risk beyond traditional risk factors, according to two longitudinal studies.

Generex announces a partnership with a company to promote their oral insulin with more than a 1000 person sales force in India.

Drug-coated stents appear to be superior to bare metal stents in both efficacy and safety in patients with diabetes, new research shows.

A large waist circumference is related to a higher risk of death even for individuals who have the same BMI [body mass index, a ratio of weight to height].

GlaxoSmithKline’s diabetes drug Avandia (rosiglitazone) has failed to show it can significantly reduce atherosclerosis in patients with type 2 diabetes.

More than half of Americans with chronic illnesses did not fill prescriptions, skipped doses of their medications, or didn’t see a doctor for a medical problem because they could not afford to, a new study showed.

While we are waiting for a once a day and once a week injectable GLP-1(exentide-4), Oramed Pharmaceuticals presented the results of a once a day oral administration of exenatide-4.